Why the study?
Does intravenous infusion of a chylomicron-like triglyceride emulsion affect the accumulation of large VLDL in healthy young men?
Population
Healthy young men
Design
Other
Follow-up
60 minutes
Authors
Loading...
Chylomicron remnants may impair VLDL conversion; hypothesis-generating for remnant lipoprotein atherogenesis in humans.
Does intravenous infusion of a chylomicron-like triglyceride emulsion affect the accumulation of large VLDL in healthy young men?
Chylomicrons and their remnants impede the normal lipolytic degradation of VLDL, which may indirectly contribute to the generation of atherogenic remnant lipoproteins.
Björkegren et al. (1996) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: